Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 1999 1(4):275-281; DOI:10.1215/15228517-1-4-275
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Winter, A. E.
Right arrow Articles by Copeland, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Clinical Therapy Trials—Quality of Life

Brain tumors in children with neurofibromatosis: Additional neuropsychological morbidity?

Anne E. De Winter, Bartlett D. Moore, III2, John M. Slopis, Joann L. Ater and Donna R. Copeland

The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030 (A.E.D., B.D.M., J.M.S., J.L.A., D.R.C.); and The University of Texas-Houston, Medical School, Houston, TX 77030 (J.M.S.)

2 Address correspondence and reprint requests to Bartlett D. Moore, III, Ph.D., Division of Pediatrics, Box 87, U.T. M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.

Abstract

Neurofibromatosis type 1 is a common autosomal dominant genetic disorder associated with numerous physical anomalies and an increased incidence of neuropsychological impairment. Tumors of the CNS occur in approximately 15% of children with neurofibromatosis, presenting additional risk for cognitive impairment. This study examines the impact of an additional diagnosis of brain tumor on the cognitive profile of children with neurofibromatosis. A comprehensive battery of neuropsychological tests was administered to 149 children with neurofibromatosis. Thirty-six of these children had a codiagnosis of brain tumor. A subset of 36 children with neurofibromatosis alone was matched with the group of children diagnosed with neurofibromatosis and brain tumor. Although mean scores of the neurofibromatosis plus brain tumor group were, in general, lower than those of the neurofibromatosis alone group, these differences were not statistically significant. Children in the neurofibromatosis plus brain tumor group who received cranial irradiation (n = 9) demonstrated weaker academic abilities than did children with brain tumor who had not received that treatment. These results suggest that neurofibromatosis is associated with impairments in cognitive functioning, but the severity of the problems is not significantly exacerbated by the codiagnosis of a brain tumor unless treatment includes cranial irradiation.




This article has been cited by other articles:


Home page
Arch NeurolHome page
R. L. Billingsley, G. W. Schrimsher, E. F. Jackson, J. M. Slopis, and B. D. Moore III
Significance of Planum Temporale and Planum Parietale Morphologic Features in Neurofibromatosis Type 1
Arch Neurol, April 1, 2002; 59(4): 616 - 622.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 1999 by Society for Neuro-Oncology